Seasonal Influenza Vaccination

& Pneumococcal Vaccination Arrangement for 2019/20

1

Vaccination Programmes/Schemes

1. Government Vaccination Programme (GVP)

2. Vaccination Subsidy Scheme (VSS)

3. School Outreach (For Seasonal Influenza

Vaccination only)

2

Seasonal Influenza Vaccination

(SIV)

3

SI Vaccines in 2018/19 had expired on

31 August 2019

Number of doses given

• Government Vaccination Programme (GVP) 492 000

• Vaccination Subsidy Schemes (VSS) 583 000

• School Outreach Vaccination Pilot Programme 121 000

Increased by

46%as compared

with 17/18

Total:

> 1 196 000

4

• Majority of institutional outbreaks of ILI was

recorded in schools including primary

schools and kindergartens/child care centres

(KGs/CCCs)

• High influenza-associated hospital admission

rates among children

School Outreach Programme

Aims to increase seasonal influenza vaccination uptake

amongst school children and prevent influenza-related

hospital admissions and complications

Why School Outreach Pilot

5

School Outreach 2018/19

6

SIV Statistics 2018/19 by target groups

7

Category

GVP

(including

RVP)

VSS

School

Outreach

Pilot

2018/19

Total no. of

doses administered

Comparison

between

2017/18 and

2018/19

Elderly aged 65 years or

above 388 000 167 000

N/A555 000

+23 600

doses

(+4.4%)

Persons aged 50 to 64 7 150 150 000N/A

157 000

+ 150 000

doses

(+2 024.0%)

Children

aged between 6

months to less

than 6 years

1 140 145 000N/A

146 000

+34 000

doses

(+30.5%)

aged between 6

years to less than

12 years

120 115 000 121 000 237 000

+160 000

doses

(+205.1%)

Total for Children 1 260 260 000 121 000 383 000

+193 000

doses

(+102.1%)

Healthcare workers 54 900 N/A N/A 54 900+9 000 doses

(+19.7%)7

School typeWithout outreach

vaccination

With outreach

vaccination

KGs/CCCs

(n=1,063)

394 / 879

(44.8%)

51 / 184*

(27.7%)

Primary schools

(n=587)

66 / 184

(35.9%)

76 / 403*

(18.9%)

Proportion of schools with ILI

outbreaks in 2018/19 winter influenza

season

38%

47%

* Note: Schools having outbreaks within 2 weeks after outreach vaccination are not

counted (1 KG/CCC & 1 primary school). One primary school with outreach SIV for

staff only was also not counted.

SIV Programmes in 2019/20

9

SCVPD Recommendations on SIV for

2019/20 Same priority groups as

recommended in the 2018/19

SIV composition

Both inactivated and live attenuated

vaccine are recommended

Take reference from

evaluation of 2018/19

Programme

10

Recommendations on SIV composition

for 2019/20 (northern hemisphere)

• Quadrivalent vaccine contains the following:

an A/ Brisbane/ 02/ 2018 (H1N1) pdm09-like virus

an A/ Kansas/ 14/ 2017 (H3N2)-like virus

a B/ Colorado/ 06/ 2017-like virus

a B/ Phuket/ 3073/ 2013-like virus

• Both inactivated influenza vaccine (IIV) and live attenuated influenza

vaccine (LAIV) are recommended for use in Hong Kong

• For IIVs, quadrivalent is preferred to trivalent due to additional

protection against one more lineage of influenza B

11

SIV Programmes in 2019/20

• School Outreach

• GVP (including

Residential Care Home

Vaccination Programme

RVP)

• VSS

Key New Initiatives

To step up SIV via

School Outreach

To enhance

workflow & increase

amount of subsidy

for School Outreach

& RVP

To cover residential

child care centres in

RVP

12

GVP

• Free vaccination to eligible groups

at HA and DH premises

at institutions under RVP

Eligible groups &

arrangement unchanged

Enhanced workflow;

Subsidy $100 per dose

13

Eligible groups of GVP 2019/20

14

Eligible groups of GVP 2019/20

* Must be Hong Kong residents

** Certificate for Waiver of Medical Charges issued by Social Welfare Department

15

Eligible groups of VSS

• Subsidized

vaccination to

eligible groups by

private doctors

1616

VSS

• Private doctors (VSS doctors) may or may not

charge extra fee

• For VSS doctors information, please visit

eHeath system (subsidies)

17

High-risk conditions (under GVP/VSS)

(Criteria: Remain the same)High-risk conditions include both risk factors for

seasonal influenza and invasive pneumococcal diseases

History of invasive pneumococcal disease, cerebrospinal fluid leakage or

cochlear implant;

Chronic cardiovascular (except hypertension without complications), lung,

liver or kidney diseases;

Metabolic diseases including diabetes mellitus or obesity (Body Mass Index

30 or above);

Immunocompromised states related to weakened immune system due to

conditions such as asplenia, Human Immunodeficiency Virus

infection/Acquired Immune Deficiency Syndrome or cancer/steroid treatment;

Chronic neurological conditions that can compromise respiratory functions or

the handling of respiratory secretions, or increase the risk of aspiration, or

those who lack the ability to take care of themselves

Children and adolescents (aged 6 months to 18 years) on long-term therapy.

18

School Outreach

• Service providers: Public-private-partnership (PPP)

vaccination teams & DH teams

• Free vaccination

• Cover more schools

Primary schools

Kindergartens (KG), Kingdergartens-cum-child-care-

centres, Child-care-centres (CCC) – pilot this year

• Cover more students

All students in participating schools, irrespective of HK

resident status, can receive free vaccination19

Primary School

Outreach

Kindergarten / Child

Care Centre Outreach

(Pilot)

Quota No quota

Eligibility All students, regardless of Hong Kong

resident status

Charge Free*

VSS Outreach (if for schools) can allow extra charge

20

Primary School

Outreach

Kindergarten / Child

Care Centre Outreach

(Pilot)

Provision of

vaccination

Mainly public-private-partnership (PPP)

outreach team

Vaccine procurement

& deliveryGovernment PPP doctors

Subsidy to PPP

doctors

HKD$100 for each

dose

HKD$260 for each

dose

21

Enrollment of School Outreach

• The Department of Health (DH) has held

briefings for stakeholders:

• In February & March 2019 for private doctors and

schools to invite them to enroll in the programme

• In June 2019 to private doctors and schools on the

preparatory arrangement and operational details

for outreach activities

• As at 1 September 2019, approximately

430 primary schools and 700 KG/CCC

have enrolled

22

Types of SIVs used under GVP, VSS,

and School Outreach

• Inactivated influenza vaccine (IIV)

• Available in quadrivalent (QIV) and trivalent (TIV) forms

• QIV is preferred to TIV due to the additional protection against

one more lineage of influenza B

• Administered through injection

• Can be used for persons aged 6 months and above

• Live attenuated influenza vaccine (LAIV)

• Administered intranasally

• Indicated for 2-49 years of age, except: those who are pregnant,

immunocompromised, or with other contraindications

(Please refer to the drug inserts for details before vaccination)

23

Types of SIVs used under GVP, VSS,

and School OutreachProgramme(s) Type of vaccines

• GVP IIV (quadrivalent) only

• VSS

• School Outreach (Free of

charge) – KG/CCC (pilot)

Doctors can choose to use IIV or

LAIV (quadrivalent)* as indicated

• School Outreach (Free of

charge) – Primary School

Outreach

IIV (quadrivalent) for most schools

(DH will test use LAIV in school

outreach to test the feasibility and

logistics arrangement.)

24

*According to vaccine supplier – limited supply of LAIV to Hong Kong for 2019/20

Reinforce Public Education

25

Reasons for receiving / not receiving SIV

(General Public)

Reasons for receiving

• 32.8% believed that vaccination is

effective in reducing the risk of

flu/ease flu-like symptoms

• 21.3% worry of getting flu/peak flu

season

• 17.5% recommended by health

care workers

• 16.6% have a habit to receive the

vaccination every year

• 13.5% know there is free /

subsidised vaccination

Reasons for not receiving

• 45.9% perceive themselves as

being healthy and will not easily

get the flu

• 14.1% are concerned about

effectiveness of SIV

• 10.4% are concerned about the

safety of SIV

• 9.7% consider vaccine is

expensive

• 8.5% have no time

Source: Seasonal influenza vaccination coverage survey for the 2015/16 season. Reported on

Communicable Disease Watch. Dec 18 – Dec 31, 2016

26

Role of HCWs in promoting SIV

Promote SIV to patients

• Be proactive in promoting, especially to persons in the priority

groups

• Clarify main concerns about effectiveness and safety of the

vaccination

Get vaccination themselves

• Reduce morbidity related to respiratory infections

• Reduce risk of transmitting influenza to patients who are at

high-risk of complications and mortality

• Strengthen capacity during peak season

27

• Work closely with health care

sectors, community partners and

education sectors to promote

vaccination

• Publicise through a series of media

activities and various channels

TV and radio (New API)

Websites / Facebook

Briefing session

Specialist interviews

Videos

Articles to newspapers and magazines

Leaflets and posters

Advertisements

Health education hotline

Public education and risk communication

28

Pneumococcal Vaccination

(PV) for the Elderly

29

PV Programmes in 2019/20

• Continue the same arrangement as 2018/19

Elderly aged 65

years or above

Have never received

pneumococcal

vaccination

Have received 23vPPV

With high-risk

conditions

One dose of free or

subsidised PCV 13

followed by one dose

of 23vPPV one year

after

One dose of free or subsidised

PCV13 mop-up vaccination

one year after the previous

dose of 23vPPV

Without high-

risk conditions

Continue to provide

one dose of free or

subsidized 23vPPV

No need to re-vaccinate

30

PV Programmes in 2019/20

• No change in eligibility under GVP and VSS

• VSS subsidy levels remain the same

• 23vPPV: HKD$250 per dose

• PCV13: HKD$730 per dose

31

Will start on 9 Oct 2019

Vaccination Subsidy

Scheme

2019/20 SIV School

Outreach (Free of charge)

– KG/CCC (pilot)

Vaccination Programmes Start Dates

Will start on 23 Oct 2019

Government Vaccination

Programme

2019/20 SIV School

Outreach (Free of charge)

– Primary School Outreach

32

Conclusion

1. Lessons learnt from 2018/19 Programmes

2. To plan, enhance and implement 2019/20

Programmes

3. Collaboration

33

Thank You

Please visit the following website for more

details:

https://www.chp.gov.hk/en/features/17980.html

Vaccination Office Enquiry Number :

2125 2125

34